Mesoestetic targets Oz pigmentation

Advanced Cosmeceuticals staff with Mesoestetic international trainer Sabine Wallez (centre)

The mesoestetic Pharma Group recently held its third depigmentation course – and officially certified its 51st ‘Specialised Depigmentation Centre’ – in Australia.

Conducted by mesoestetic international trainer Sabine Wallez, the course aimed to give clinics “a cutting edge advantage” in treating pigmentation which is “the third most common skin problem (after wrinkles and sagging)”.

Acccording to mesoestetic, which is recognised as a global leader in topical depigmentation, 90 percent of Caucasian people aged over 50 have skin blemishes, and depigmenting treatments now represent “over 20 percent of the total cosmetic market”.

Catherine Biedermann, the managing director of Advanced Cosmeceuticals (the local distributor of mesoestetic), says the course was an incredible opportunity for skin therapists “to learn first-hand”  about the causes of depigmentation and its successful treatment.

It was attended by therapists from previously certified Specialised Depigmentation Centres  across the country (all certified clinics must complete the course once every three years to maintain their status) as well as therapists from clinics that were “new to the program”.

Biedermann says that all the attendees are now part of “an exclusive group of advanced skincare clinics with cutting edge technology, knowledge and training giving them a competitive edge”.

“Pigmentation is a growing, global issue,” she says.

“It [pigmentation] is in fact one of the most common reasons for visiting a cosmetic dermatologist as it is such a stubborn skin condition to treat which is why mesoestetic has spent the last 20 years cultivating cosmelan [a one-off in-salon skin brightening mask combined with followup homecare products].

“It [cosmelan] remains the worldwide benchmark treatment for pigmentation with an effectiveness rate of 95 percent in 99 percent of cases.”

For more news and updates, subscribe to our weekly newsletter.

Leave a comment: